Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Radiat Res. 2017 Aug 16;188(5):579–590. doi: 10.1667/RR14831.1

FIG. 3.

FIG. 3

Comparison of survivin-mediated radio-adaptive survival responses in HCT116 TP53 WT (panel A) and isogenic TP53 null cells (panel B). Cytoplasmic (C) and nuclear (N) survivin levels were determined by ELISA (panels C and D). P values were determined by comparing the survivin levels in each treatment group with its corresponding control. Each experiment was repeated three times and error bars represent SEM.